☰

Brittany L. Allen-Petersen, Ph.D. - Publications

Affiliations: 
2012 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Oncology, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tinsley SL, Allen-Petersen BL. PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen. Nar Cancer. 4: zcac002. PMID 35118387 DOI: 10.1093/narcan/zcac002  0.455
2019 Farrington CC, Yuan E, Mazhar S, Izadmehr S, Hurst L, Allen-Petersen BL, Janghorban M, Chung E, Wolczanski G, Galsky M, Sears R, Sangodkar J, Narla G. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers. The Journal of Biological Chemistry. PMID 31822503 DOI: 10.1074/Jbc.Ra119.011443  0.576
2019 Allen-Petersen BL, Sears RC. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 31392631 DOI: 10.1007/S40259-019-00370-5  0.485
2019 Allen-Petersen BL, Sears RC. The use of protein phosphatase 2A activators in combination therapies for pancreas cancer. Oncotarget. 10: 2008-2009. PMID 31007842 DOI: 10.18632/Oncotarget.26772  0.371
2019 Auciello FR, Bulusu V, Oon C, Tait-Mulder J, Berry M, Bhattacharyya S, Tumanov S, Allen-Petersen BL, Link J, Kendsersky ND, Vringer E, Schug M, Novo D, Hwang RF, Evans RM, et al. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discovery. PMID 30837243 DOI: 10.1158/2159-8290.Cd-18-1212  0.435
2019 Langer EM, Allen-Petersen BL, King SM, Kendsersky ND, Turnidge MA, Kuziel GM, Riggers R, Samatham R, Amery TS, Jacques SL, Sheppard BC, Korkola JE, Muschler JL, Thibault G, Chang YH, et al. Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting. Cell Reports. 26: 608-623.e6. PMID 30650355 DOI: 10.1016/J.Celrep.2018.12.090  0.424
2019 Langer E, Su Y, Joly M, Allen-Petersen B, Farrell A, Worth P, Liefwalker D, Link J, Sheppard B, Sears R. Abstract I16: KRAS and environmental signals regulate MYC to drive lineage plasticity, pancreas cancer progression, and therapeutic resistance Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-I16  0.575
2018 Allen-Petersen BL, Risom T, Feng Z, Wang Z, Jenny ZP, Thoma MC, Pelz KR, Morton JP, Sansom OJ, Lopez CD, Sheppard B, Christensen DJ, Ohlmeyer M, Narla G, Sears RC. Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma. Cancer Research. PMID 30389701 DOI: 10.1158/0008-5472.Can-18-0717  0.551
2017 Farrell AS, Joly MM, Allen-Petersen BL, Worth PJ, Lanciault C, Sauer D, Link J, Pelz C, Heiser LM, Morton JP, Muthalagu N, Hoffman MT, Manning SL, Pratt ED, Kendsersky ND, et al. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nature Communications. 8: 1728. PMID 29170413 DOI: 10.1038/S41467-017-01967-6  0.421
2016 Langer EM, Wang X, Liang J, Allen-Petersen BL, Kendsersky ND, Risom T, Pelz C, Sears RC. Abstract B51: Modeling the intrinsic and extrinsic influences on breast cancer phenotypic heterogeneity using mouse models and three-dimensional bioprinting Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B51  0.547
2015 Sears R, Farrell A, Wang X, Liang J, Janghorban M, Su Y, Allen-Petersen B, Ohlemeyer M, Goutham N. Abstract IA10: Post-translational regulation of MYC's oncogenic activity Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Ia10  0.572
2015 Allen-Petersen BL, Farrell AS, Jenny ZP, Daniel CJ, Wang Z, Lopez CD, Christensen DJ, Narla G, Sheppard BC, Sears RC. Abstract B21: Protein phosphatase 2A (PP2A) activation functions synergistically with kinase inhibition in pancreatic cancer Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-B21  0.573
2015 Link JM, Allen-Petersen B, Gunderson A, Jorgens D, Dorrell C, Hooper J, Streeter P, Grompe M, Coussens L, Gray J, Hardaker H, Lopez CD, Sears RC, Sheppard BC. Abstract B118: Developing a molecular and cellular atlas of pancreatic disease Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B118  0.44
2015 Farrell AS, Allen-Petersen B, Daniel CJ, Wang X, Wang Z, Christensen DJ, Sheppard B, Sears RC. Abstract A89: Targeting the MYC activation and degradation pathway for the treatment of pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A89  0.593
2015 Allen-Petersen BL, Farrell AS, Daniel CJ, Wang Z, Lopez CD, Christensen DJ, Sheppard BC, Sears RC. Abstract A104: Phosphatase activation and kinase inhibition as a novel therapeutic strategy for pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A104  0.574
2015 Wang X, Farrell A, Janghorban M, Allen-Petersen B, Liang J, Risom T, Ohlmeyer M, Narla G, Sears RC. Abstract SY38-03: Targeting post-translational activation of MYC for the treatment of cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Sy38-03  0.431
2014 Janghorban M, Farrell AS, Allen-Petersen BL, Pelz C, Daniel CJ, Oddo J, Langer EM, Christensen DJ, Sears RC. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: 9157-62. PMID 24927563 DOI: 10.1073/Pnas.1317630111  0.596
2014 Farrell AS, Allen-Petersen B, Daniel CJ, Wang X, Wang Z, Rodriguez S, Impey S, Oddo J, Vitek MP, Lopez C, Christensen DJ, Sheppard B, Sears RC. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Molecular Cancer Research : McR. 12: 924-39. PMID 24667985 DOI: 10.1158/1541-7786.Mcr-13-0542  0.582
2014 Allen-Petersen BL, Carter CJ, Ohm AM, Reyland ME. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer. Oncogene. 33: 1306-15. PMID 23474764 DOI: 10.1038/Onc.2013.59  0.619
2013 Farrell A, Daniel C, Wang Z, Allen-Petersen B, Christensen D, Sheppard B, Lopez CD, Sears R. Abstract 1976: Targeting the PP2A tumor suppressor for the treatment of human pancreatic cancer. Cancer Research. 73: 1976-1976. DOI: 10.1158/1538-7445.Am2013-1976  0.567
2010 Allen-Petersen BL, Miller MR, Neville MC, Anderson SM, Nakayama KI, Reyland ME. Loss of protein kinase C delta alters mammary gland development and apoptosis. Cell Death & Disease. 1: e17. PMID 21364618 DOI: 10.1038/Cddis.2009.20  0.576
Show low-probability matches.